Objective: To examine the appropriateness and feasibility of cognitive rehabilitation for people with dementias associated with Parkinson's in a pilot randomised controlled study.
approaches might offer complementary or alternative strategies, yet there remains limited research examining cognitive interventions in PD, and no study has applied these approaches in PDD or DLB. 12 A previous systematic review raised concerns regarding the scientific rigour of existing studies and highlighted the lack of randomised controlled designs. 12 Cognitive intervention studies in PD without dementia have primarily used cognitive training (CT), the guided repeated practice of tasks to target specific cognitive functions. CT may provide some benefits to PD patients without dementia for domains of working memory, processing speed, and executive functioning, but negligible or no improvements in memory, attention, visuospatial abilities, depression, quality of life, and activities of daily living. 13 Because these latter domains become increasingly impaired as dementia progresses, there is a need to develop treatments that can mitigate not only the effects of increasing cognitive decline, but also support quality of life and independence. Cognitive rehabilitation (CR) 14 supports people with dementia to develop and use evidence-based strategies that compensate for, or reduce the impact of, their cognitive and behavioural difficulties, focussing on improving functioning in everyday activities. It employs a person-centred approach with assistance from a trained therapist to devise and apply meaningful goals, commensurate to the individual's needs and abilities. The strategies employed may be compensatory (using reminders, calendars, alarms) and/or restorative (spaced retrieval learning, mnemonics) depending on the goal selected. Similar to CR, cognitive strategy training (CST) also uses an individualised approach using strategies to achieve goals relating to daily function. A case-series study of CST for 7 people with PD without dementia but reporting subjective cognitive decline and selfidentified functional issues reported that CST was feasible and potentially effective. 15 The study did not include people with dementia, and thus the application of goal-focussed rehabilitation
approaches has yet to be applied in PDD and DLB. The efficacy of CR for people with Alzheimer's disease (AD) has previously been indicated in a pilot study 16 and a large multi-centre randomised controlled trial (RCT) of CR is currently underway to assess its effectiveness for people with AD and other dementias excluding PDD and DLB. 17 Recently, we showed that people with PDD and DLB were able to engage in goal setting for CR, with goals being selected most often in self-management and orientation, medication adherence, learning new skills, and maintaining social and leisure activities. 18 The aims of the current study were to examine the appropriateness and feasibility of CR for people with PDD and DLB, and explore indications of the treatment's efficacy relative to an active control condition or treatment as usual. Additional aims included assessing the usefulness of outcome measures and obtaining effect sizes to inform the development of future RCTs of CR in PDD and DLB. Informed written consent was obtained prior to participation. Exclusion criteria were a lack of stability of prescribed PD medications, cognitive enhancers or psychotropic medication (such as substantial additions to medication in the 4 weeks before the trial or planned changes during the period of the trial), other major psychiatric disorder not related to PD, major depression, and other significant neurological disease.
| Participants

| Procedures
Participants completed baseline demographic, clinical, and cognitive assessments, and a goal-setting interview for CR was conducted, as described previously. 18, 24 Following the baseline visits, participants were randomised to 1 of the 3 treatment arms: CR, relaxation therapy (RT) or treatment-as-usual (TAU). Post-intervention and follow-up assessments were conducted with the researcher 2 and 6 months from randomisation, respectively.
| Interventions
The CR treatment comprised 8 weekly 1-hour sessions with the therapist (J.R.). 24 The intervention included the use of evidence-based methods to assist the participant to pursue the agreed goals.
Key points
• Goal orientated cognitive rehabilitation uses goal setting and evidence-based strategies focussing on improving functioning in everyday activities in people with dementia.
• There are no previous controlled studies of cognitive rehabilitation in dementias associated with Parkinson's.
• This pilot randomised controlled trial showed that cognitive rehabilitation was superior to treatmentas-usual and relaxation therapy for primary outcomes in dementias associated with Parkinson's.
• Cognitive Rehabilitation is feasible and potentially effective for dementias associated with Parkinson's but requires further study.
These methods included compensatory strategies and/or restorative approaches to circumvent difficulties relating to orientation, planning, the retention of learned information, and recall (for examples of goals and strategies used for CR see Supplementary Table 1a) . Participants were encouraged to practice their strategies between therapy sessions, with the assistance of the carer (where available). Carers were invited to participate in the therapy sessions to support between-session implementation.
The RT intervention also comprised 8 weekly 1-hour sessions with the therapist (J.R.). Participants were taught progressive muscle relaxation and breathing exercises in accordance with the study's RT treatment protocol (see Supplementary Table 1b) . Participants were encouraged to practice these techniques between sessions.
The TAU arm continued with the standard care available through their health care provider. 26 were measured at baseline, 2-month, and 6-month follow-up assessments.
| Randomisation and blinding
Participants rated their current attainment and satisfaction with their attainment for these goals on a scale of 1 to 10, with 1 = unable to carry out or perform task/extremely dissatisfied with attainment and 10 = able to carry out or perform task without difficulty/extremely satisfied with attainment. ; and the client services receipt inventory (CSRI) 37 to monitor medication prescription.
| Secondary outcomes
Levodopa-equivalent dose (LED) was computed according to standardised formulae. 38 The carer assessment included the carer ratings for participants' goal attainment (BGSI); HADS, GSES, WHOQOL-BREF; EQ5D3L; the Neuropsychiatric Inventory Questionnaire (NPI-Q) 39 ; and the Relatives' Stress Scale (RSS). 
| Statistical methods
Analyses were completed for each outcome measure for the 2-month and 6-month follow-ups using an ANCOVA model, with baseline scores as covariates, group allocation and stratification variables as fixed factors. As this was a pilot study intended to provide information that will inform the sample size calculation for a full scale randomised trial, no formal power calculation was undertaken. The original published trial design aimed to recruit 15 in each arm. 18, 24 One of the key objectives of this pilot study was to identify the most robust and sensitive outcome measures for development of a larger RCT, and therefore due to the exploratory nature of this study, Bonferroni
corrected P values and confidence intervals were deemed too stringent for the purposes of the current analyses. Missing data were imputed with mean substitution when a participant did not have a score on a measure but was still enrolled in the study for that time point. All statistical tests were 2-tailed, and P values less than 0.05 were classified as statistically significant.
| RESULTS
| Recruitment and retention
The CORD-PD CONSORT diagram is shown in Figure 1 . The recruitment rate was 38.8% (participants assessed at baseline / potential participants invited − participants not meeting inclusion criteria), with 31 participants recruited to the study. The attrition rate following randomisation (dropout/randomised) was 14% (4/29). One participant was included in the study due to a screening error but was later excluded at baseline. Reasons for withdrawal after randomisation were significant deterioration in cognition (n = 1) or health status (n = 2) and a lack of motivation to continue participation (n = 1). Treatment adherence for participants randomised to intervention conditions is shown in Supplementary Information Table 2 .
| Participants
At the intervention time point, there were 29 participants with PDD or DLB and 26 carer participants. Table 1 shows participant and carer characteristics for the overall sample and across treatment groups.
There were no significant differences between these groups on baseline measures. Table 2 shows participants' outcomes across treatment groups and Table 3 . Table 3 shows standardised effect size estimates (d) and confidence intervals for statistically significant differences between groups on primary and secondary outcomes for participants. Table 4 shows carers' outcomes across treatment groups and time points.
| Outcomes
| Carers
Group differences favouring CR were found for carers ratings' of participants' goal attainment (F(1,15) = 6.44, P = 0.01), carers' selfratings for the environmental domain of WHOQOL-BREF (F(1,15) = 4.41, P = 0.03), and carers' self-ratings for overall health using the ED5D3L visual analogue (F(1,15) = 3.62, P = 0.05). Table 3 shows standardised effect size estimates (d) and confidence intervals for statistically significant differences between groups on carers' outcomes.
| Blinding
An exact binomial test performed on blinding control data revealed no indications that the researcher was able to correctly identify participants' treatment randomisation allocations at either the 2-month (9 out of 26 participants correctly identified their group allocation, P = 1) and 6-month (12 out of 25 participants correctly identified their group allocation, P = 0.14) assessments.
| DISCUSSION
The CORD-PD pilot RCT is the first study to apply goal-oriented CR for dementias associated with PD, using an individualised intervention to address goals that are meaningful to the person and that take account of the person's cognitive and functional abilities. People with *There were no significant differences between these groups on baseline measures. mild to moderate PDD and DLB are able to participate in goal setting for CR using the BGSI, 18 Index and PDQ8), as well as better performance on a delayed recall task, was found for CR compared with TAU. Note: A positive effect size indicates that the first group is greater/higher than second group; a negative effect sign indicates the second group is greater/ higher than the first group (for HADS Depression and Anxiety, PDQ8, and the RSS, higher scores indicate lower well-being or greater symptomatology).
Abbreviations: BGSI, Bangor Goal Setting Interview; CR, cognitive rehabilitation; ED5D3L, Euroqol Questionnaire-short version; Environ., environmental; GSES, Generalised Self-Efficacy Scale; HADS, Hospital Anxiety and Depression Scale; PDQ8, Parkinson's Disease Questionnaire-8; Psych., psychological; RBMT, Rivermead Behavioural Memory Test; RSS, Relative's Stress Scale; RT, relaxation therapy; TAU treatment as usual; VAS, visual analogue scale; WHOQOL-BREF, World Health Organisation Quality of Life Scale-Brief version.
The CR group reported improvements on goals relating to medica- At the post-intervention assessment, carer ratings for participants' attainment were significantly higher in the CR than in the RT group, but at follow-up, they were significantly higher in the CR than in both the RT and TAU groups. Additionally, carers in the CR group at followup reported lower stress levels and higher ratings for overall health and an environmental component of quality of life relative to carers in the control groups. It is possible that improvements in participants' attainment are not immediately noticeable to third parties until they achieve significant progress with their goals with a reduction in care-related duties only at a certain level of independence.
A recent CT trial involving PD patients without dementia demonstrated that improvements to specific cognitive functions 42 were maintained 1 year following treatment and reduced the risk of developing cognitive impairment. 43 The feasibility of CST for PD patients without dementia has also been demonstrated. 15 Following on from this work, our results show that the benefits of cognitive interventions might extend to patients with more severe cognitive impairments seen in PDD and DLB. While CT involves the practice of abstract exercises to train cognitive functions, our approach focuses on developing and practicing strategies to assist directly with actual daily activities which may be more relevant for people with mild to moderate dementia. There is increasing interest in combined treatments in non-pharmacological research in PD including exercise. 44, 45 Avenues for future research could include investigating the impact of exercise, CT, and CR, in combination or in comparison with each other, on participant outcomes.
| Limitations and future directions
One limitation of the current study is the small sample size, which might affect the generalisability of these results. Nonetheless, this sample size is typical of pilot psychosocial studies in PD. [46] [47] [48] Medium to large effects were found in this study in favour of CR relative to the control conditions for primary and some secondary outcomes, suggesting that these results may be replicated in a larger study. The array of outcome measures is large, increasing the likelihood of type-1 error inflation. However, a key objective of this study was to assess the usefulness of various outcome measures and calculate effect sizes to inform outcome selection for a fully powered trial. DLB participant recruitment was disproportionately small, precluding subtype analyses.
We did not use a clinical instrument to determine dementia stage and instead relied on the clinical judgement. Similarly, we used one measure, the ACE-III global cut-off score, to guide participant selection.
Due to the fluctuating nature of cognitive impairment apparent in PDD and DLB, such screening methods may have underestimated or overestimated cognitive impairment in some patients. We excluded patients without objective cognitive impairment but who may have shown other neuropsychiatric changes (eg, apathy, depression) that could have benefited from this behavioural intervention. Because the emergence of neuropsychiatric symptoms is associated with increasing cognitive impairment in PD, 49 these symptoms might represent prodromal stages of dementia. It would be interesting to examine whether CR provides benefits for patients experiencing only behavioural changes, such as apathy. Finally, while patients were encouraged to practice or implement strategies between CR sessions with carer help, we did not formally monitor practice and cannot assess whether the quality, frequency, duration of practice, or involvement of a carer between-sessions influenced the intervention's efficacy.
Despite these caveats, the study has several strengths. It adopted the gold-standard RCT approach and included an active control condition that gave equal time and attention to participants to examine the role of possible placebo effects and other nonspecific treatment variables. The study also ensured blinding of researchers to participants' treatment allocations. CR is individualised to the participants' abilities and priorities, consistent with the preference of people living with these conditions for receiving a personalised approach for their difficulties. 50 The results will inform the development of a larger RCT, powered to provide definitive evidence for the effectiveness of CR against standard or usual care. The next stages of the research will involve consolidating the therapeutic procedures and determining the assessment outcomes for a future larger trial which will also examines cost-effectiveness alongside multi-disciplinary care for people with PDD or DLB.
| CONCLUSIONS
Despite 
